RxDoctor Payments DataLook up a doctor →

Jodi Rose, NP

Family · Cleveland, TNNPI 1124494513

Payments from drug & device makers

$56,987in general payments, 2019–2025

Across 1,140 payments — averaging $49.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceutical Holding Company Ltd.$20K
  • Biohaven Pharmaceuticals, Inc.$18K
  • AbbVie$2K
  • UCB, Inc.$2K
  • Livanova USA, Inc.$1K
  • Acadia Pharmaceuticals Inc$916
  • plus $12K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biohaven Pharmaceutical Holding Company Ltd.37$20,194
Biohaven Pharmaceuticals, Inc.125$18,137
AbbVie(2 entities)191$2,232
UCB, Inc.97$1,810
Livanova USA, Inc.4$1,291
Acadia Pharmaceuticals Inc43$916
EMD Serono, Inc.35$863
Lundbeck LLC34$794
Teva Pharmaceuticals USA, Inc.31$733
Neurocrine Biosciences, Inc.33$676
Neurelis, Inc.29$676
Pfizer42$646
AstraZeneca(2 entities)25$626
Argenx US, Inc.40$607
Biogen34$605
Eisai Inc.29$592
Novartis31$579
Bristol Myers Squibb25$457
Lilly USA, LLC27$442
SK Life Science, Inc.18$374
Sumitomo Pharma America, Inc.23$247
MDD US Operations, LLC11$218
Sunovion Pharmaceuticals Inc.25$213
CSL Behring11$207
Kyowa Kirin, Inc.9$182
Catalyst Pharmaceuticals, Inc.8$181
Otsuka America Pharmaceutical, Inc.9$176
Johnson & Johnson(2 entities)9$163
Upsher-smith Laboratories LLC6$142
Jazz Pharmaceuticals Inc.5$142
Nevro Corp.1$141
Amneal Pharmaceuticals LLC5$126
Corium, LLC9$124
Sanofi4$94
Avanir Pharmaceuticals, Inc.6$94
Banner Life Sciences, LLC5$89
Octapharma USA, Inc.4$85
Scilex Pharmaceuticals Inc.5$80
Acorda Therapeutics, Inc5$73
Genentech USA, Inc.3$71
Impel Pharmaceuticals Inc.4$65
Arbor Pharmaceuticals, Inc.4$61
ANI Pharmaceuticals, Inc.2$58
Cycle Pharmaceuticals Inc3$58
Tanabe Pharma America, Inc.4$57
Mallinckrodt Hospital Products Inc.3$55
Supernus Pharmaceuticals, Inc.3$54
Amylyx Pharmaceuticals, Inc.2$52
TG Therapeutics, Inc.2$44
E.r. Squibb & Sons, L.L.C.2$43
Medtronic2$41
Boston Scientific1$38
Amgen2$36
Axsome Therapeutics, Inc.2$35
Adamas Pharmaceuticals, Inc.2$32
Vanda Pharmaceuticals Inc.2$30
Grifols USA, LLC1$26
Takeda Pharmaceuticals U.S.A., Inc.1$25
Averitas Pharma Inc.1$23
Almatica Pharma LLC1$19

How this compares

$56,987 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$19,819
Medicare patients
152
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Cleveland

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →